HA
KRON

HHLR Advisors’s Kronos Bio KRON Stock Holding History

HHLR Advisors’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-153,698
Closed -$3.22M – 83
2021
Q3 		$3.22M Sell
153,698
-279,738
-65% -$6.01M 0.04% 74
2021
Q2 		$10.4M Sell
433,436
-225,000
-34% -$5.7M 0.11% 68
2021
Q1 		$19.3M Hold
658,436
– – 0.19% 49
2020
Q4 		$19.7M Buy
+658,436
New +$20.7M 0.16% 59

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HHLR Advisors's KRON Position: Q4 2021 in Review

HHLR Advisors sold out of Kronos Bio (KRON) in Q4 2021, closing a stake of 153,698 shares — an estimated $3.22M sold.

HHLR Advisors first reported a position in KRON in Q4 2020 and held it in 4 quarters. The position peaked at $19.7M in Q4 2020. 81 funds tracked by Wall St. Rank hold KRON as of Q4 2021.

  • HHLR Advisors reported no remaining Kronos Bio position as of Q4 2021 after selling out during the quarter.
  • HHLR Advisors sold 153,698 Kronos Bio shares in Q4 2021, an estimated $3.22M.
  • HHLR Advisors first reported a position in Kronos Bio in Q4 2020 and held it in 4 quarters.
  • HHLR Advisors's Kronos Bio position peaked at $19.7M in Q4 2020.
  • 81 funds tracked by Wall St. Rank held Kronos Bio as of Q4 2021.

Based on HHLR Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.